US HB4215 | 2023-2024 | 118th Congress
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on June 20 2023 - 25% progression
Action: 2023-06-23 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on June 20 2023 - 25% progression
Action: 2023-06-23 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To require the Secretary of Health and Human Services to establish reference prices for prescription drugs for purposes of Federal health programs, and for other purposes.
Title
End Price Gouging for Medications Act
Sponsors
Rep. Debbie Dingell [D-MI] |
History
Date | Chamber | Action |
---|---|---|
2023-06-23 | House | Referred to the Subcommittee on Health. |
2023-06-20 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Armed Services, Veterans' Affairs, Oversight and Accountability, and Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2023-06-20 | House | Introduced in House |
Same As/Similar To
SB2044 (Same As) 2023-06-20 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/118th-congress/house-bill/4215/all-info |
Text | https://www.congress.gov/118/bills/hr4215/BILLS-118hr4215ih.pdf |